Profile
Illinois Ventures is a venture capital firm based in Chicago, Illinois, founded in 2000. The firm is closely affiliated with the University of Illinois and focuses on investing in companies with ties to the university. With a team of experienced professionals, Illinois Ventures aims to support early-stage companies in their growth journey, leveraging the university's innovative spirit.
The firm primarily invests in seed and early-stage companies across a variety of sectors, including information technologies, artificial intelligence, cancer therapeutics, engineering, physical sciences, ag tech, deep tech, and life sciences. Illinois Ventures typically invests in companies based in the United States, with a focus on those emerging from research and innovation. The firm manages several funds, including the Deep Tech Strategic Fund, which has an AUM of $48 million.
Notable investments by Illinois Ventures include Ocient - data analytics for compute-intensive workloads, Revolution Medicines - cancer therapeutics, EarthSense - autonomous ag robots, Cystetic Medicines - molecular prosthetics for cystic fibrosis, and MESH ++ - WiFi solutions. These investments highlight the firm's commitment to backing transformative technologies and solutions.
Industry
Illinois Ventures Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Deep Tech Strategic Fund
|
Venture Capital (VC)
|
Biotechnology
Healthcare Services
AI
Technology
CleanTech
HealthTech
|
Pre-seed
Seed
|
North America
|
$5-10 m
|
$48 M
|
October 2024
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.